> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Report from Clinical Trial Training in India
- URL: https://www.fdaweb.com/report-from-clinical-trial-training-in-india/
- Published: 2017-07-12T12:00:00.000Z
- Updated: 2026-09-14T22:33:52.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5139114

FDA assistant commissioner of international programs **Leslie Ball** and two colleagues recently participated in a two-day joint training workshop for Indian regulators, academic representatives, and the drug industry on scientific and ethical standards for clinical trials in Mumbai, India. Ball and the other FDAers report on their experiences in an *FDA Voice* blog [post](https://blogs.fda.gov/fdavoice/index.php/2017/07/fda-collaborates-to-promote-safety-quality-in-clinical-trials-done-in-india/?source=govdelivery&utm%5Fmedium=email&utm%5Fsource=govdelivery). They say the program included an intensive whirlwind of sessions, discussions, and case studies addressing key quality and ethical issues in clinical trials.

Workshop participants included sponsors, contract research organizations, firms conducting bioavailability or bioequivalence studies, clinical investigators, regulators, and academic researchers. “These joint workshops sought to provide practical training on emerging issues, regulatory updates, clinical trial data integrity, and inspectional methods,” they write. Specific workshop goals included: 

- identifying general concepts in inspections of clinical investigators, clinical test sites, ethics committees, and bioanalytical study sites;
- identifying techniques for maintaining data integrity in clinical trials; and
- reviewing inspections to develop evidence and determine appropriate observations to include in inspection reports.